Evidence map›Paper›PMID 42510636›Full record

ReviewAntioxidants (Basel, Switzerland)2026

Hedgehog/GLI Signaling at the Interface of Sterol Metabolism, Mitochondrial ROS Signaling and Cellular Plasticity.

Nicolas Jullien, Sabine François

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nicolas JullienRadiobiology Unit, Department of Radiation Effects, French Armed Forces Biomedical Research Institute (IRBA), 91220 Brétigny-sur-Orge, France.ORCID 0000-0001-6584-8991
Sabine FrançoisRadiobiology Unit, Department of Radiation Effects, French Armed Forces Biomedical Research Institute (IRBA), 91220 Brétigny-sur-Orge, France.ORCID 0000-0002-3193-6122

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classically, Hedgehog (Hh)/GLI signaling is recognized as a developmental pathway. Increasing evidence indicates that it also contributes to cellular metabolism and adaptation to stress. In this review, we examine the involvement of Hh/GLI signaling in mitochondrial function and redox homeostasis. Mitochondria are major sources of reactive oxygen species (ROS), which act as signaling molecules in cellular adaptation. Hh signaling both influences and responds to ROS production: GLI activity is regulated by redox-dependent mechanisms, and Hh signaling is associated with mitochondrial bioenergetics, dynamics and quality-control pathways. These interactions may contribute to metabolic adaptation in physiological and pathological settings. We also discuss the contribution of sterol metabolism to this regulatory network. Cholesterol and oxysterols modulate Smoothened activation, linking lipid metabolism to mitochondrial function and redox balance. NRF2-dependent antioxidant pathways maintain mitochondrial redox homeostasis, although direct mechanistic crosstalk with Hh/GLI signaling remains incompletely defined. At the tissue level, Hh signaling is involved in responses to irradiation, inflammation, fibrosis, aging and regeneration. Depending on the biological context, pathway activation may support adaptive responses or contribute to tissue dysfunction. Overall, current evidence supports a role for Hh/GLI signaling in mitochondrial redox adaptation through the integration of metabolic and oxidative signals.

Indexed as

cellular plasticityGLI transcription factorshedgehog signalingmitochondriaNRF2reactive oxygen speciesredox homeostasissterol metabolism

Identifiers

PMID42510636
PMCPMC13406015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.